# Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy

> **NCT07741110** · — · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 141 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma (NPC)

## Interventions

- **GENETIC:** Next generation sequencing
- **GENETIC:** Immunohistochemistry/CISH

## Key facts

- **NCT ID:** NCT07741110
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-01
- **Primary completion:** 2008-02-28
- **Final completion:** 2008-02-28
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741110, "Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*